IRIS
RANIERI, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.218
NA - Nord America 5.672
AS - Asia 2.813
SA - Sud America 176
Continente sconosciuto - Info sul continente non disponibili 13
AF - Africa 9
OC - Oceania 5
Totale 14.906
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.633
IE - Irlanda 1.644
CN - Cina 1.492
UA - Ucraina 1.093
SE - Svezia 845
IT - Italia 713
DE - Germania 539
RU - Federazione Russa 490
SG - Singapore 457
FI - Finlandia 361
HK - Hong Kong 337
FR - Francia 275
IN - India 240
TR - Turchia 235
BR - Brasile 154
GB - Regno Unito 104
CZ - Repubblica Ceca 56
CA - Canada 32
NL - Olanda 32
BE - Belgio 31
AT - Austria 13
EU - Europa 9
JP - Giappone 9
PK - Pakistan 8
CL - Cile 7
ES - Italia 7
IR - Iran 6
PH - Filippine 6
EC - Ecuador 5
RO - Romania 5
AR - Argentina 4
IL - Israele 4
MX - Messico 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
LT - Lituania 3
NZ - Nuova Zelanda 3
ZA - Sudafrica 3
AU - Australia 2
ID - Indonesia 2
JO - Giordania 2
MA - Marocco 2
MY - Malesia 2
PL - Polonia 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BD - Bangladesh 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
IM - Isola di Man 1
KE - Kenya 1
LU - Lussemburgo 1
MN - Mongolia 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
SA - Arabia Saudita 1
TH - Thailandia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 14.906
Salva come PNG Salva come JPEG
Città #
Dublin 1.644
Chandler 999
Jacksonville 772
Nyköping 548
Dearborn 541
Nanjing 380
Munich 366
Hong Kong 333
Wilmington 239
Ashburn 206
Helsinki 203
New York 200
Santa Clara 197
Princeton 179
Singapore 162
San Mateo 157
Beijing 148
Nanchang 145
Ann Arbor 122
Boardman 119
Foggia 98
Moscow 96
Shenyang 84
Woodbridge 83
Des Moines 72
Tianjin 69
Hebei 68
Bari 60
Brno 53
Kunming 51
Seattle 51
Jiaxing 45
Changsha 43
Rome 39
Pune 36
Hangzhou 33
Los Angeles 33
Jinan 30
Brussels 29
Falls Church 29
Milan 29
Guangzhou 28
Shanghai 28
Hilden 25
Zhengzhou 25
Ningbo 23
Toronto 20
Augusta 19
Noci 17
Norwalk 17
Taizhou 17
Changchun 16
Lanzhou 16
Fuzhou 15
Stevenage 15
Auburn Hills 13
Manfredonia 13
Houston 12
Catania 10
Florence 10
Nuremberg 10
Saint Petersburg 10
San Francisco 10
Falkenstein 9
Jyväskylä 9
Leawood 9
Orange 9
Rotterdam 9
Shenzhen 9
São Paulo 9
Wuhan 9
Düsseldorf 8
Latina 8
London 8
Molfetta 8
Redwood City 8
Acquaviva Delle Fonti 7
Belo Horizonte 7
Bisceglie 7
Jhelum 7
Paris 7
Washington 7
Bologna 6
Fairfield 6
Hefei 6
Kocaeli 6
Ottawa 6
Tokyo 6
Vienna 6
Brasília 5
Brescia 5
Jinhua 5
Lauterbourg 5
Rio de Janeiro 5
Rockville 5
San Severo 5
Tappahannock 5
Bitonto 4
Borås 4
Fremont 4
Totale 9.408
Salva come PNG Salva come JPEG
Nome #
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità 307
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells 234
Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation 229
CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib-associated renal carcinoma antigens with ubiquitous or restricted tissue expression 221
Metodo per il dosaggio del fattore di crescita epidermico (EGF) e del peptide-1 chemiotattico dei monociti umani (MCP-1) in un campione biologico e relativo kit diagnostico 209
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction 142
Tumori del rene e della via urinaria: cosa deve sapere il nefrologo 139
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità 132
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità. 128
GLI INIBITORI DELLA TRASCRITTASI INVERSA (RT) DOWN-REGOLANO LA PROLIFERAZIONE CELLULARE E INDUCONO IL DIFFERENZIAMENTO NEL CARCINOMA RENALE A CELLULE CHIARE. 127
Biosynthesis of C3 by human mesangial cells. Modulation by proinflammatory cytokines. 124
The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy. 124
Activated coagulation factor X: a novel mitogenic stimulus for human mesangial cells 122
High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. 120
cell carcinoma cell line and use thereof. 120
The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. 118
Pentraxin 3: A novel biomarker for predicting progression from prostatic inflammation to prostate cancer 115
Trapidil inhibits human mesangial cells proliferation: effect on PDGF-β receptor binding and expression 114
A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation 114
IgA nephropathy: pros and cons for a familial disease. 112
“Urinary excretion and renal expression of monocyte chemotactive peptide-1 (MCP-1) and epidermal growth factor expression (EGF) in children with reflux and obstructive nephropathies 111
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 110
Jak3 mutations predict poor survival in patients with clear cell renal carcinoma 108
Renal Carcinoma Cell Line and Use Thereof 106
REVERSE TRANSCRIPTASE (RT) INHIBITORS INDUCE DIFFERENTIATION AND UPREGULATE MHC CLASS I IN HUMAN RENAL CLEAR CELL CARCINOMA. 106
ESCREZIONE URINARIA DI MONOCYTE CHEMOTACTIC PEPTIDE-1 ED EPIDERMAL GROWTH FACTOR NELL’UROPATIA OSTRUTTIVA IN ETÀ PEDIATRICA 105
“Concentrazioni urinarie di EGF (epidermal growth factor) urinario in bambini affetti da grave uropatia ostruttiva e da reflusso”. 105
WAIT AND SEE: IS IT A POSSIBLE OPTION IN ASYMPTOMATIC PATIENTS WITH MESH EXPOSURE? 105
AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): PKD1 AND PKD2 MUTATIONAL SCREENING IN 100 ITALIAN PATIENTS 104
Atti 52° Congresso Nazionale della Società Italiana di Nefrologia. Genova, 21-24 Settembre, 2011 104
Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 104
Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes 103
Additive effect of cyclosporine and low density lipoproteins on transforming growth factor-beta 1 and monocyte chemotactic protein-1 expression in human mesangial cells. 102
CD2AP mutations are associated with sporadic nephrotic sindrome and focal segmental glomerulosclerosis (FSGS). 102
IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro. 101
Espressione renale di epidermal growth factor (EGF) e monocyte chemotactic peptide-1 (MCP-1) in bambini affetti da stenosi del giunto pielo-ureterale. 99
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 99
BEAT: Bioinformatics Exon Array Tool to store, analyze and visualize Affymetrix GeneChip Human Exon Array data from disease experiments. 97
Establishment and characterization of a highly immunogenic human renal carcinoma cell line 97
[Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?] 97
Renal cortical complement C3 gene expression in IgA nephropathy 96
Renal expression and urinary concentration of EGF and IL-6 in acutely dysfunctioning kidney transplanted patients 96
Urine profiling by SELDI-TOF/MS: Monitoring of the critical steps in sample collection, handling and analysis 95
Biosimilar: can we manage biopharmaceutical heterogeneity? 94
Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1. 94
Linea cellulare di carcinoma renale e suo uso 94
Renal and upper urinary tract tumors: what the nephrologist should know 93
Reclassification of glomerulopathies: which role for the podocyte? 93
Urine protein profile of IgA nephropathy may predict the response to ACE-inhibitor therapy 93
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells. 92
Urinary epidermal growth factor concentration in patients affected by ADPKD. 92
JAK3/STAT5/6 pathway alterations are associated with immune deviation in CD8+ T cells in renal cell carcinoma patients 92
Immunologic Response to RCC. 91
Proteomic profile of CD24+ CD133+ renal multipotent progenitors (RMP) 91
POTENTIAL SALIVARY PROTEOMIC MARKERS OF ORAL SQUAMOUS CELL CARCINOMA 91
PROTEOMICA E RENE UN APPROCCIO INNOVATIVO ALLO STUDIO DELLE MALATTIE RENALI 90
Growth factors and their receptors in the progression of renal damage. 90
Influence of hemodialysis on interleukin-6 production and gene expression by peripheral blood mononuclear cells. 90
Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy. 89
MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma. 89
Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis 89
Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection 89
Cultured human mesangial cells produce both type 1 and type 2 plasminogen activators inhibitors 89
Beyond pre-analytical and analytical concerns in the study of synovial fluid proteome: Description of an optimized gel-based protocol 88
Abnormalities of the IgA immune system in members of unrelated pedigrees from patients with IgA nephropathy. 87
CD40L proinflammatory and profibrotic effects on proximal tubular epithelial cells: role of NF-kappaB and lyn. 86
Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunihistochemistry and in situ study. 85
Is Berger's disease a hereditary nephritis? 85
Monitoring antitumor efficacy of rapamycin in Kaposi sarcoma. 85
Cytotoxic T-Cells Methods and Protocols Preface 85
Salivary proteomic signatures of oral squamous cell carcinoma. 85
Espressione renale di PAI-1 (Plasminogen activator inhibitor-1) ed angiotensinogeno (AGT) in bambini con nefropatia ostruttiva (NO). 83
Altered expression of the clock gene machinery in kidney cancer patients 83
Exposure to low- vs. iso-osmolar contrast agents induces NADPH-dependent Reactive Oxygen Species (ROS) genereration in a cellular model of renal injur 83
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer. 82
Diagnostic and prognostic markers of renal cell carcinoma 82
TGF-β promotes immune suppression by inhibiting Treg cell apoptosis 81
Rapamycin Inhibits PAI-1 Expression and Reduces Interstitial Fibrosis and Glomerulosclerosis in Chronic Allograft Nephropathy 81
Monitoring biological action of rapamycin in renal transplantation. 81
TLR7 and TLR8 as targets for tumor immunotherapy 81
Identification of GLA gene deletions in Fabry patients by Multiplex Ligation-dependent Probe Amplification (MLPA) 81
Disease-associated bias in T helper type 1(Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma. 81
Platelet-derived growth factor and proliferative glomerulonephritis. 80
In vitro immunogobulin production in relatives of patients with IgA Nephropathy. 80
MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy 80
Expression of platelet derived growth factor receptors in normal and diseased human kidney: an immunohistochemistry and in situ study. 79
Profiles of immunoregolatory cytokine production in vitro in patients with IgA nephropathy and their kindred 79
Ramipril inhibits in vitro human mesangial cell proliferation and platelet-derived growth factor expression. 78
Diabetes Mellitus (DM) reduces survival in patients with renal cell carcinoma (RCC) : role of OGG1 and tuberine 78
Chronic rhinosinusitis with nasal polyposis (CRSwNP): the correlation between expression of Galectin-10 and Clinical-Cytological Grading (CCG) 78
Translational mini-review series on vaccines: Dendritic cell-based vaccines in renal cancer. 77
REVERSE TRANSCRIPTASE INHIBITORS INDUCE CELL DIFFERENTIATION AND ENHANCE THE IMMUNOGENIC PHENOTYPE IN HUMAN RENAL CELL CARCINOMA 77
Ischemia-reperfusion injury-induces abnormal dendritic cell traffic in the transplanted kidney with delayed graft function 77
CTL ELISPOT AssayCytotoxic T-Cells 77
Ischemia-reperfusion induces glomerular and tubular activation of pro-inflammatory and anti-apoptotic pathways: differential modulation by rapamycin. 76
VHL gene alterations in Italian patients with isolated renal cell carcinomas. 76
Expression of transforming growth factor-beta 1 in thyroid tumor 75
Current insights in renal cell cancer pathology 75
Dendritic cells transduced with an adenovirus vector enconding Epstein-Barr virus latent mebrane protein 2B: a new modality for vaccination 75
Saliva analysis by Surface Enhanced laser Desorption/Ionization Time of Flight Mass Spectrometry (SELDI-TOF/MS): from sample collection to data analysis 75
Totale 10.205
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.659
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.659
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020261 0 0 0 0 0 0 0 0 0 33 206 22
2020/20211.547 179 5 167 58 180 114 222 43 295 263 17 4
2021/20221.139 157 14 16 33 119 46 41 79 187 139 39 269
2022/20234.250 372 177 237 274 257 365 42 312 1.957 54 88 115
2023/20241.056 120 34 49 23 73 387 58 87 17 14 14 180
2024/20252.727 196 47 113 103 125 454 484 268 815 122 0 0
Totale 15.409